/Companies

Waiv

9 known investors

Find your way into Waiv

Sign up to see every warm intro you have to Waiv

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Waiv team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Waiv develops AI-based diagnostic tests for precision oncology, using machine learning and foundation models to support biomarker discovery and multimodal diagnostic workflows. A spin-out of Owkin, it works with healthcare institutions and biopharma partners to bring clinically validated tests to patients.

Investors · 9

Also in the syndicate · 3

CRB Digital Health IIIleadCRB Health TechSistaFund

Funding

SEC filings, press & company announcements

$33M disclosed across 1 of 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Waiv do?
Waiv develops AI-based diagnostic tests for precision oncology, using machine learning and foundation models to support biomarker discovery and multimodal diagnostic workflows. A spin-out of Owkin, it works with healthcare institutions and biopharma partners to bring clinically validated tests to patients.
Who are Waiv's investors?
Waiv's investors include Serena, Sista, Alpha Intelligence Capital, Karista, OTB Ventures, Serena Ventures.
How much funding has Waiv raised?
Waiv has disclosed $33M raised across 1 of its 2 known rounds.